Literature DB >> 7606314

Risk of traffic accident injury after a prescription for a benzodiazepine.

C I Neutel1.   

Abstract

The objective of this study was to assess the risk of hospitalization for injuries received in traffic accidents after a first prescription for benzodiazepines (BZD) was filled. Saskatchewan Health supplied study populations of 78,000 adults who received BZD hypnotics, 148,000 who received BZD anxiolytics, and 98,000 control subjects. These populations were monitored for 2 months after the index prescription fill-date for hospitalizations due to traffic accidents. Analysis showed an odds ratio (OR) of 3.9 (1.9 to 8.3) for persons taking BZD hypnotics and an OR of 2.5 (1.2 to 5.2) for those taking BZD anxiolytics, with regards to hospitalization due to traffic accidents within 4 weeks after the prescription was filled. Within 2 weeks after the prescription was filled, the Or had risen to 6.5 (1.9 to 22.4) for hypnotics and 5.6 (1.7 to 18.4) for anxiolytics. After 1 week, the ORs were even higher (9.1 and 13.5), but the confidence limits were wide. The highest risk groups were the youngest age group (20 to 39 years old) and males. From a public health view, the high ORs are of concern and action for prevention is needed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606314     DOI: 10.1016/1047-2797(94)00112-7

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  37 in total

1.  A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France.

Authors:  J Menzin; K M Lang; P Levy; E Levy
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

2.  Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a veterans population.

Authors:  Dustin D French; Thomas N Chirikos; Andrea Spehar; Robert Campbell; Heidi Means; Tatjana Bulat
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies.

Authors:  Ludivine Orriols; Louis-Rachid Salmi; Pierre Philip; Nicholas Moore; Bernard Delorme; Anne Castot; Emmanuel Lagarde
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-08       Impact factor: 2.890

4.  Road traffic accidents and psychotropic medication use in The Netherlands: a case-control study.

Authors:  Silvia Ravera; Nienke van Rein; Johan J de Gier; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

Review 5.  Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.

Authors:  U Fuhr
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

6.  Fatal crashes from drivers testing positive for drugs in the U.S., 1993-2010.

Authors:  Fernando A Wilson; Jim P Stimpson; José A Pagán
Journal:  Public Health Rep       Date:  2014 Jul-Aug       Impact factor: 2.792

7.  Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.

Authors:  Tim R M Leufkens; Annemiek Vermeeren; Beitske E Smink; Peter van Ruitenbeek; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2007-01-12       Impact factor: 4.530

Review 8.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Use of Sedative-Hypnotics and Mortality: A Population-Based Retrospective Cohort Study.

Authors:  Jae-Won Choi; Joonki Lee; Sun Jae Jung; Aesun Shin; Yu Jin Lee
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

10.  Prescription medicines and the risk of road traffic crashes: a French registry-based study.

Authors:  Ludivine Orriols; Bernard Delorme; Blandine Gadegbeku; Aurore Tricotel; Benjamin Contrand; Bernard Laumon; Louis-Rachid Salmi; Emmanuel Lagarde
Journal:  PLoS Med       Date:  2010-11-16       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.